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A hereditary congenital condition characterized by a fibro-osseous lesion sharing some
features with fibrous dysplasia and affecting the middle aspect of the mandible is
presented. The condition was initially described as congenital monostotic fibrous dysplasia
in two siblings, a male and a female. However, there is sufficient evidence that the
disorder is autosomal dominant since it has been encountered in two of four children,
both males, of the female propositus and one child, a boy, of the male propositus.
All patients presented at birth or right after birth with enlargement of the middle part
of the mandible. Radiographs from affected individuals have shown mesomandibular
enlargement with irregular trabeculation akin of “ground-glass” appearance. Histologically,
samples from all patients revealed woven bone proliferation in a cellular fibroblastic
stroma. Interestingly, the originally described siblings, now in their 30s, have no evidence
of jaw lesions either radiographically or clinically, thus indicating that the condition is
self-limiting or self-resolving. An autosomal dominant mode of inheritance with apparent
male predilection is favored. The molecular basis of this condition is currently unknown.
However, the location of the lesions in the middle aspect of the mandible suggests
dysregulation of Bone Morphogenetic Protein (BMP) signaling since BMPs regulate
mandibular morphogenesis in utero, particularly in the medial region as well as postnatal
bone remodeling. Immunohistochemical evaluation for a BMP-binding protein Twisted
Gastrulation (TWSG1) revealed mosaic pattern of staining, with some cells, including
osteoclasts, strongly stained and others exhibiting faint or no staining, thus supporting
active regulation of BMP signaling within the lesion. Future investigations will determine
if dysregulation of BMP signaling plays a causative role or rather reflects secondary
activation of repair mechanisms and/or bone remodeling.
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INTRODUCTION
Benign fibro-osseous lesions (BFOLs) encompass a group of
pathologic processes characterized by replacement of normal
bone by generally cellular fibrous tissue and newly formed
osseous, or so-called cemento-osseous, deposits. Included in the
group of BFOL of the jaws are: (1) ossifying fibroma, a neo-
plasm, (2) fibrous dysplasia a condition associated with known
mutations to the G protein subunit α (Gsα), encoded by the
GNAS gene at 20q13, that couples hormone receptors to intracel-
lular cAMP, and (3) a variety of fibro-osseous processes referred
to as (cemento)-osseous dysplasias subclassified by their clin-
icoradiographic characteristics. Familiarity with their clinical,
radiographic, and in some cases histopathologic characteristics is
important for management that can vary, depending on the type,
from periodic observation, surgical recontouring for functional
and esthetic purposes, to tumor resection.
Most cases are non-hereditary. However, the literature does
contain cases of pedigrees with a certain type of BFOL. There
are few reports of familial gigantiform cementoma (Cannon
et al., 1980; Young et al., 1989; Oikarinen et al., 1991; Finical
et al., 1999), florid osseous dysplasia (Musella and Slater, 1989;
Coleman et al., 1996), periapical cemental dysplasia (Sedano
et al., 1982; Thakkar et al., 1993), as well as alleged examples of
familial fibrous dysplasia with craniofacial involvement (Talley,
1952; Reitzik and Lownie, 1975; Lemli, 1977; Alvarez-Arratia
et al., 1983; Pierce et al., 1985; Sarkar et al., 1993; Hsissen et al.,
1997). Also, a pedigree has been described in which one mem-
ber featured “polyostotic fibrous dysplasia” while other members
cherubism (Zohar et al., 1989). Fibro-osseous lesions of the
jaws, referred to by some authors as cemento-ossifying fibromas
(Jackson et al., 1990; Aldred et al., 2006), have been encoun-
tered in patients with hereditary hyperparathyroidism (Rosen and
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Palmer, 1981) caused by mutations in the tumor suppressor gene
HRPT2.
In 1979, El Deeb et al. (1979) described, under the term con-
genital monostotic fibrous dysplasia, two siblings, a male and a
female, presenting with a fibro-osseous process of the anterior
middle aspect of the mandible exhibiting, clinicoradiographically
and histopathologically, features suggestive of fibrous dysplasia.
In 2006, the son of the female sibling presented with the same
lesion. Extensive evaluation of the family was undertaken that
resulted in the identification of affected offsprings of the two
siblings. As it will be elucidated later in this report, this con-
dition is unique, self-regressing, and disappearing with age. In
our opinion, the term autosomal dominant mesomandibular
fibro-osseous dysplasia (ADMFOD) best describes this condi-
tion. In addition, since misregulation of the Bone Morphogenetic
Protein (BMP) pathway has been suggested to play a role in the
pathogenesis of fibrous lesions in the bone (Kiss et al., 2010),
we examined (by immunohistochemistry) if BMP binding pro-
tein Twisted Gastrulation (TWSG1) is present in either bone




Formalin-fixed paraffin-embedded tissue was sectioned at 5μM
and mounted on Superfrost Plus slides (Fisher Scientific,
Pittsburgh, PA). Sections were deparaffinized in xylenes and rehy-
drated through a series of graded ethanol. Endogenous peroxidase
activity was blocked by incubating sections in a 3% hydro-
gen peroxide/methanol solution for 10min and then washed
in PBS. Slides were placed in Antigen Unmasking Solution
diluted to manufacturer’s recommendation (Vector Laboratories,
Burlington, CA) and microwaved for 20min. Once cooled,
slides were washed and then blocked in PBS containing 5%
goat serum (Invitrogen, Carlsbad, CA) and 0.3% Triton X-100
(Fisher Scientific) for 60min at room temperature. Sections
were incubated with monoclonal anti-hTWSG1 antibody (2F3;
Abnova, Taipei City, Taiwan) at 1:500 dilution overnight at 4◦C.
Detection was accomplished using SuperPicture Kit (DAB, Broad
Spectrum, Life Technologies, Carlsbad, CA) following manufac-
turer’s instructions.
BACKGROUND
DESCRIPTION OF THE PEDIGREE
The description of the propositus and his sibling has been pre-
viously published (El Deeb et al., 1979). However, to thoroughly
present the condition we deem it necessary to review the char-
acteristics of the initially affected siblings in conjunction with
the recently discovered affected members of the pedigree. The
pedigree is depicted in Figure 1.
Patient II-2 (propositus)
The male propositus presented at 3 months of age with pro-
gressing congenital enlargement of the anterior middle aspect
of the mandible measuring 7.0 × 2.0 × 1.0 cm (Figures 2A,B).
His medical history was non-contributory and he was the out-
come of a normal pregnancy and delivery with no known family
FIGURE 1 | Family pedigree.
history of jaw lesions or consanguinity. Radiographically, the
lesion was generally radiopaque with ill-defined borders and fea-
tured displacement and splaying of teeth and mimicking fibrous
dysplasia (Figure 2C). Serum calcium, phosphorus and alkaline
phosphatase levels were within normal limits. A biopsy revealed
spindle cell proliferation of fibroblast-like cells with areas of
early osteoid formation and deposits of irregular spicules of
woven bone with limited osteoblastic rimming (Figure 2D). The
rendered diagnosis at that time was BFOL, probable fibrous
(fibro-osseous) dysplasia. Follow-up of the patient was recom-
mended with no additional surgical procedures to be undertaken
at that time.
Subsequent radiographs at age 10 and 12 months (Figure 2E)
revealed progressive enlargement with distal and lingual expan-
sion and increase in the density of the abnormal bone but without
obvious facial abnormality. Progressive regression of the lesion
was appreciated at 26 and 36 months (Figure 2F), which was
attributed by the clinicians “to the normal growth of the patient,”
meaning, most likely, that the lesion ceases to grow and becomes
incorporated into the developing jaw. Throughout this period the
patient did not reveal any evidence of café-au-lait spots or other
skeletal abnormalities.
The male propositus, now at 33 years of age, does not present
clinical (Figure 2G) or radiographic (Figure 2H) abnormalities
of the mandible. Only arrested development with signs of attri-
tion of the right permanent central mandibular incisor and
focal diastema were appreciated. He has two children, an unaf-
fected daughter (III-1) and an affected son (III-2). His son has
not undergone any radiographic or surgical evaluation of his
lesion.
Patient II-3
In 1978, the sibling of the propositus, a female infant, presented
with congenital mesomandibular enlargement (Figure 3A).
Radiographic (Figure 3B) and histopathologic (Figure 3C) fea-
tures were essentially similar to her brother’s. Follow-up at
12 months revealed persistent enlargement with splaying of teeth
(Figure 3D) and signs of regression. Judging from the progressive
reduction of both patients’ lesions it was decided that no addi-
tional surgical treatment was required. After 1980 there was no
recorded follow-up in the charts of both siblings.
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FIGURE 2 | Patient II-2. (A) Profile of the patient exhibiting
enlargement and protrusion of the mandible, (B) lobular enlargement
of the mandible, (C) occlusal radiograph depicting enlargement of the
middle aspect of the mandible characterized by a ground-glass pattern,
(D) loose cellular fibroblastic proliferation with deposits of woven bone,
(E) radiograph revealing irregular ground glass-like appearance of the
mandible and splaying of teeth. (F) profile of the patient at age 3
year, (G) patient as an adult at age 33 years. No evidence of jaw
enlargement was present, (H) no evidence of ground glass appearance
or enlargement.
FIGURE 3 | Patient II-3. (A) Lobular enlargement of the mandible,
(B) ground glass appearance of bone and splaying of teeth, (C) brisk
fibroblastic proliferation and irregular bone deposits with limited
osteoblastic rimming, (D) at age 12 months there was enlargement of the
mandible and splaying of teeth.
Patient III-5
In 2006, a 3-month-old male infant was examined by Ioannis
G. Koutlas for progressive enlargement of the middle aspect of
the mandible. Initially, relationship of the infant to any of the
siblings described above was unknown to the examiner. Upon
further discussion of the striking resemblance of the lesion to
the reported patients by El Deeb et al. (1979) and the rarity
of this congenital lesion, a direct familial relationship to the
previous cases was established. Prior to being seen in the clinic,
the infant had radiographic evaluation and incisional biopsy at a
local hospital diagnosed as fibrous dysplasia. Histologic prepara-
tions revealed an essentially similar benign fibro-osseous process
(Figure 4A).
Clinical evaluation of the patient’s mother (patient II-3) did
not reveal any clinical lesions. There was only transposition
between the right mandibular canine and first premolar. There
was no evidence of radiographic abnormality. A follow-up of
the male infant was recommended. At 12 (Figure 4B) and 36
months the lesion was still present, albeit smaller. The decrease
in size was apparently relative to the normal increase in size of
the mandible. In addition, at 12 months, left sided limb enlarge-
ment was noticed (approximately 1 cm leg size discrepancy) as
well as slight asymmetry between the right and lefts hands and
right and left feet. The patient underwent a complete skeletal
survey at age 13 months. Besides the mandibular lesion there
were no other osseous abnormalities present to suggest a sim-
ilar dysplastic process in other bones. The left femur and tibia
were minimally larger than the right but with no intrinsic bone
abnormality. Follow up radiographic evaluation of the chest,
pelvis, hands and feet including bone length studies have been
undertaken from 2007 to 2011. The last bone length study con-
firmed the right lower extremity measuring 54.4 cm from the
superior femoral head to the tibial plafond while the left lower
extremity measured 55.3 cm. The left femur was 0.5 cm longer
than the right, and the left tibia also 0.5 cm longer than the
right. During this period of 5 years, bilateral coxa valga defor-
mities were also appreciated; however, they showed improvement
with time. Chest evaluation did not reveal any abnormalities
of osseous structures. Since other affected members did not
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FIGURE 4 | Patient III-5. (A) Irregular deposits of bone in a brisk fibroblastic
stroma, (B) enlargement of the mandible with splaying of teeth,
(C–F) immunodetection of TWSG1 in fibrous tissue, osteoclasts, and
osteocytes within the lesion, (C) mosaic pattern throughout the sample
with areas of high expression next to areas of low or no detectable
expression, even within the same cell type, (D) 40x magnification of the
boxed area in (C) showing primarily fibroblastic TWSG1 expression,
(E) osteoclast in a resorption pit shows a high level of TWSG1 expression.
TWSG1 expression is also detected in fibrous tissue adjacent to bony
deposit, (F) 40x magnification of the boxed area in (C) showing strong
TWSG1 expression in the osteoclast and expression in osteocytes.
report or reveal, after clinical evaluation, such clinical limb
anomalies, these findings are most likely unrelated to the jaw
lesion.
In order to examine if BMP binding protein TWSG1 was
present in either bone cells or fibrous tissue within the lesion,
sections of lesional tissue obtained from this patient were
evaluated by immunohistochemistry with monoclonal antibody
against human TWSG1. Immunoreactivity was observed in a
mosaic pattern within the lesion with some groups of cells
stained strongly and other groups exhibiting low to no stain-
ing (Figures 4C–F). The staining was cytoplasmic and detected
in fibroblasts, osteocytes and the strongest staining was seen in
osteoclasts.
Patient III-6
In 2009, another affected male infant was born to the female
patient II-3 with mesomandibular enlargement, however, not
as noticeable as his brother’s (Figure 5A). The lesion was
also biopsied exhibiting a similar benign fibro-osseous process
(Figure 5B). The family has two older unaffected children.
FIGURE 5 | Patient III-6. (A) Subtle enlargement of the mandible and
(B) loose fibroblastic proliferation with woven bone deposits. Very limited
osteoblastic rimming was noted.
DISCUSSION
Inherited fibro-osseous lesions of the jaws are rare and appear in
the literature as examples of gigantiform cementomas (Cannon
et al., 1980; Young et al., 1989; Oikarinen et al., 1991; Finical
et al., 1999), familial florid osseous dysplasia (Musella and Slater,
1989; Coleman et al., 1996), and periapical cemental dysplasias
(Sedano et al., 1982; Thakkar et al., 1993). The term gigantiform
cementoma has been used in the past as a synonym for florid
osseous dysplasia and examples of familial gigantiform cemen-
tomas were grouped with familial cases of florid osseous dysplasia
(Coleman et al., 1996). Also, prior to establishment of cemento-
osseous lesions as a separate entity, they have been published as
examples of familial fibrous dysplasia (Talley, 1952). Gigantiform
cementomas and florid osseous dysplasia tend to follow the cycle
of fibrous dysplasia and they cease to grow around the fifth decade
of life. Currently, the term gigantiform cementoma is restricted to
certain sporadic or familial cases presenting as multifocal rapid
and expansive enlargements of both the maxilla and mandible
leading to facial deformity, which can be occasionally severe
(Cannon et al., 1980; Young et al., 1989; Finical et al., 1999).
A most unique case of hereditary fibro-osseous lesion was
described by Chatterjee and Mazumder (1967) originating in
the mucoperiosteum of the middle aspect of both the maxilla
and the mandible, affecting the alveolus and extending to the
palate causing substantial disfigurement. It has been referred to
as “hippopotamus face” (Kundu and Pan, 1979), an unfortunate
characterization.
Very little is known about the pathogenesis of florid osseous
dysplasia and gigantiform cementoma, sporadic, or familial. We
were able to identify a single reference, presented as an abstract,
of GNAS mutation in two examples of florid cemento-osseous
dysplasia and one case of cemento-ossifying fibroma (Al-Adnani
et al., 2005). The validity of these results has not been con-
firmed in other studies that failed to show GNAS mutations in
cases of ossifying (cementifying) fibromas and cemento-osseous
dysplasias (Toyosawa et al., 2007; Patel et al., 2010).
Prior to the identification of the gene associated withMcCune-
Albright syndrome and cases of polyostotic and monostotic
fibrous dysplasia, Dr. Happle postulated that certain sporadic
syndromes that display a mosaic pattern of involvement of skin
and organs (McCune-Albright syndrome, Schimmelpenning-
Feuerstein-Mims syndrome, Proteus syndrome) are the result
of an autosomal “dominant” lethal gene leading to loss of the
zygote in utero (Happle, 1987). In order to survive, mutated
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cells must be intermingled with normal cells creating a mosaic.
This mosaic can result from either an early somatic or a gametic
half chromatid mutation. Now it is known that fibrous dyspla-
sia, monostotic, polyostotic, or as part of the McCune-Albright
syndrome is caused by postzygotic (somatic) mutations in the
gene encoding the alpha subunit of the stimulatory G pro-
tein within the GNAS complex locus (Weinstein et al., 1991;
Riminucci et al., 2006). Depending on the timing of such muta-
tions, patients will have widespread or limited manifestations. It
has been also shown that individual lesions of fibrous dysplasia
are themselves a mosaic of mutated and normal cells (Bianco
et al., 1998). With time, mutated cells population is decreased
with normal cells predominating thus leading to arrested growth
of lesions. A recent study comparing bone tissue samples from
patients with fibrous dysplasia to patients without it, besides
confirming the involvement of G protein coupled pathway, impli-
cated also BMP signaling pathway in the pathogenesis of these
lesions (Kiss et al., 2010). Fibrous dysplasia and non-fibrous
dysplasia subjects could be clearly separated by differences in
the expression of BMP2, BMP4, BMPR1A, BMPR2, and other
members of the BMP pathway. It has been postulated that since
mutant cells in fibrous dysplasia are clonal fibroblast-like osteo-
progenitor cells demonstrating high expression of the c-fos proto-
oncogene, fibrous dysplasia may be after all a neoplasm (Cohen,
2001).
Although it is well established that the mutations causing
fibrous dyplasia occur postzygotically, thus excluding the possi-
bility of the disease to be inherited, there are reported cases of
familial fibro-osseous lesions, clinically and histologically, simi-
lar or even indistinguishable from fibrous dysplasia (Reitzik and
Lownie, 1975; Lemli, 1977; Alvarez-Arratia et al., 1983; Pierce
et al., 1985; Sarkar et al., 1993). They are presumably either the
result of gametic half chromatid mutation or hereditary condi-
tions caused by a presently unknown gene mutation that leads to
a phenotype similar to fibrous dysplasia. Linkage studies in these
families are necessary to confirm the proposed diagnoses of famil-
ial fibrous dysplasia. The only pedigree among those reported as
alleged examples of familial fibrous dysplasia with jaw manifesta-
tion is the family presented by Pierce et al. (Pierce et al., 1985).
The investigators did not succeed in finding a mutation in GNAS
or in the gene causing cherubism (Mangion et al., 2000). Based
on the published clinical, radiographic, and histologic figures it
appears that the family described by Pierce et al. (Pierce et al.,
1985, 1996), represents either familial florid osseous dysplasia or
a unique entity certainly different from fibrous dysplasia. Finally,
the family described by Zohar et al. (Zohar et al., 1989) as pre-
senting with a combination of fibrous dysplasia and cherubism
has just familial cherubism.
The condition affecting the family described herein was previ-
ously referred to in the literature as monostotic fibrous dysplasia
(El Deeb et al., 1979). Based on the above argument against the
hereditary nature of fibrous dysplasia and the observations that
a) it affected the mandibular midline, hardly a preferred site for
fibrous dysplasia, as well as b) its clinical behavior characterized
by not only a self-limiting process but a self resolving one, we
decided to use the term fibro-osseous dysplasia. We elected not
to refer to the process as osteofibrous dysplasia, to distinguish
it from the familial form of osteofibrous dysplasia (Hunter and
Jarvis, 2002; Karol et al., 2005).
Osteofibrous dysplasia, known also as “osteitis fibroma,” a
“variant of fibrous dysplasia,” and “ossifying fibroma of long
bones,” is a benign bone dysplastic process affecting primarily the
cortex of the tibia and/or the fibula of skeletally immature patients
(Park et al., 1993). Patients often present with anterolateral bow-
ing of the affected bones that often lead to fractures (Karol et al.,
2005). Rarely, lesions disappear spontaneously (Campanacci and
Laus, 1981). Histologically, osteofibrous dysplasia is character-
ized by fibroblastic proliferation associated with woven bone
rimmed by osteoblasts. Because of the presence of osteofibrous
dysplasia-like areas in adamantinomas a close relationship of
the two lesions has been suggested, with osteofibrous dysplasia
being a precursor to or a regressive form of adamantinoma. No
adamantinoma has occurred in patients with the rare familial
form of osteofibrous dysplasia (Karol et al., 2005). Also, cases
of osteofibrous dysplasia have not shown any GNAS mutation
(Sakamoto et al., 2000).
The molecular mechanism associated with the familial fibro-
osseous condition presented in this paper is unknown. However,
the location of the lesions in the middle aspect of the
mandible suggests dysregulation of BMP signaling. BMPs regu-
late mandibular morphogenesis, particularly in the medial region
(Ferguson et al., 2000; Mina et al., 2002; MacKenzie et al., 2009).
Moreover, differential expression of genes in the BMP path-
way has been reported to distinguish patients with and without
fibrous dysplasia (Kiss et al., 2010), and activation of BMP path-
way due to mutations in BMP type 1 receptor has been linked to
fibrodysplasia ossificans progressiva (Shore et al., 2006; Fukuda
et al., 2009). BMPs regulate a number of cellular processes,
including proliferation, differentiation, migration, apoptosis, and
epithelial-mesenchymal interactions (Hallahan et al., 2003; von
der Hardt et al., 2007; Wagner et al., 2010). Postnatally, BMPs
play a role in regulating tissue homeostasis in physiological and
pathological conditions, such as tissue regeneration (Simic and
Vukicevic, 2007; Larman et al., 2009), bone remodeling (Pham
et al., 2011), immune function (Passa et al., 2011; Tsalavos et al.,
2011), and cancer (Thawani et al., 2010; Buijs et al., 2012).
BMP signaling is modulated in the extracellular space by BMP-
binding proteins Noggin, Chordin, Chordin-like 1, TWSG1, and
others (Ross et al., 2001; Scott et al., 2001; Balemans and Van Hul,
2002; Larman et al., 2009). In this paper, we limited the evaluation
to the expression of TWSG1 as an example of a BMP-binding pro-
tein because of its known role in regulating BMP activity during
mandibular morphogenesis (MacKenzie et al., 2009) and post-
natal bone remodeling (Sotillo Rodriguez et al., 2009), both of
which are relevant to the described pathology, as well as pre-
viously validated detection methods (Sun et al., 2010; Johnston
et al., 2012). Expression of TWSG1 in the fibrous and osseous ele-
ments of the lesion suggests a role for BMP regulation. A high
level of expression of TWSG1 in osteoclasts that are present in
the resorption pits is consistent with its role in regulating BMP
signaling in osteoclastogenesis (Sotillo Rodriguez et al., 2009). It
also points to a possible role of active bone remodeling or other
reparative mechanisms in limiting the extent of the lesion. Both
BMPs and TWSG1 have been implicated in tissue regeneration
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(Simic and Vukicevic, 2007; Larman et al., 2009). It remains to
be determined if other components of the BMP pathway are
expressed and whether dysregulation of BMP signaling plays a
causative role or rather reflects secondary activation in response
to tissue damage. It is conceivable that localized upregulation of
BMP antagonists may limit inappropriate activation of BMP sig-
naling in the medial region of the mandible, contributing to the
resolution of the lesions. Mutational analysis of genes in BMP
pathway, including those encoding BMP ligands, BMP-binding
proteins, BMP receptors, and downstream targetsMsx1 andMsx2
(Vainio et al., 1993), may provide insight into the pathogenesis of
this disease.
In summary, we present additional information on the clinico-
pathologic features of the family initially reported by El Deeb et al.
(El Deeb et al., 1979) and we argue against the characterization of
it as a familial form of monostotic fibrous dysplasia. We propose
the term ADMFOD. It is a self-resolving unique fibro-osseous
process among BFOL of the jaws.
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